FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 R Boellaard, R Delgado-Bolton, WJG Oyen, F Giammarile, K Tatsch, ... European journal of nuclear medicine and molecular imaging 42, 328-354, 2015 | 2812 | 2015 |
Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma ME Juweid, S Stroobants, OS Hoekstra, FM Mottaghy, M Dietlein, ... Journal of clinical oncology 25 (5), 571-578, 2007 | 1674 | 2007 |
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 R Boellaard, MJ O’Doherty, WA Weber, FM Mottaghy, MN Lonsdale, ... European journal of nuclear medicine and molecular imaging 37, 181-200, 2010 | 1581 | 2010 |
Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging DW Bartlett, H Su, IJ Hildebrandt, WA Weber, ME Davis Proceedings of the National Academy of Sciences 104 (39), 15549-15554, 2007 | 992 | 2007 |
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial F Lordick, K Ott, BJ Krause, WA Weber, K Becker, HJ Stein, S Lorenzen, ... The lancet oncology 8 (9), 797-805, 2007 | 947 | 2007 |
Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging WA Weber, K Ott, K Becker, HJ Dittler, H Helmberger, NE Avril, ... Journal of clinical oncology 19 (12), 3058-3065, 2001 | 857 | 2001 |
Noninvasive Imaging of αvβ3 Integrin Expression Using 18F-labeled RGD-containing Glycopeptide and Positron Emission Tomography R Haubner, HJ Wester, WA Weber, C Mang, SI Ziegler, SL Goodman, ... Cancer research 61 (5), 1781-1785, 2001 | 809 | 2001 |
Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations N Avril, CA Rose, M Schelling, J Dose, W Kuhn, S Bense, W Weber, ... Journal of clinical oncology 18 (20), 3495-3502, 2000 | 694 | 2000 |
Synthesis and radiopharmacology of O-(2-[18F] fluoroethyl)-L-tyrosine for tumor imaging HJ Wester, M Herz, W Weber, P Heiss, R Senekowitsch-Schmidtke, ... Journal of Nuclear Medicine 40 (1), 205-212, 1999 | 650 | 1999 |
Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics R Haubner, HJ Wester, F Burkhart, R Senekowitsch-Schmidtke, W Weber, ... Journal of Nuclear Medicine 42 (2), 326-336, 2001 | 643 | 2001 |
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary … ME Caplin, E Baudin, P Ferolla, P Filosso, M Garcia-Yuste, E Lim, ... Annals of Oncology 26 (8), 1604-1620, 2015 | 633 | 2015 |
Noninvasive Visualization of the Activated αvβ3 Integrin in Cancer Patients by Positron Emission Tomography and [18F]Galacto-RGD R Haubner, WA Weber, AJ Beer, E Vabuliene, D Reim, M Sarbia, ... PLoS medicine 2 (3), e70, 2005 | 626 | 2005 |
Positron emission tomography in non–small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use WA Weber, V Petersen, B Schmidt, L Tyndale-Hines, T Link, C Peschel, ... Journal of Clinical Oncology 21 (14), 2651-2657, 2003 | 620 | 2003 |
Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment HA Wieder, BLDM Brucher, F Zimmermann, K Becker, F Lordick, A Beer, ... Journal of Clinical Oncology 22 (5), 900-908, 2004 | 578 | 2004 |
Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction K Ott, WA Weber, F Lordick, K Becker, R Busch, K Herrmann, H Wieder, ... Journal of Clinical Oncology 24 (29), 4692-4698, 2006 | 565 | 2006 |
Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis N Avril, M Menzel, J Dose, M Schelling, W Weber, F Jänicke, W Nathrath, ... Journal of Nuclear Medicine 42 (1), 9-16, 2001 | 555 | 2001 |
Impact of animal handling on the results of 18F-FDG PET studies in mice BJ Fueger, J Czernin, I Hildebrandt, C Tran, BS Halpern, D Stout, ... Journal of Nuclear Medicine 47 (6), 999-1006, 2006 | 539 | 2006 |
ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms G Delle Fave, D O''Toole, A Sundin, B Taal, P Ferolla, JK Ramage, ... Neuroendocrinology 103 (2), 119-124, 2016 | 504 | 2016 |
O-(2-[18F]Fluoroethyl)-l-tyrosine and l-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study WA Weber, HJ Wester, AL Grosu, M Herz, B Dzewas, HJ Feldmann, ... European journal of nuclear medicine 27, 542-549, 2000 | 494 | 2000 |
Prostate cancer molecular imaging standardized evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-ligand PET/CT M Eiber, K Herrmann, J Calais, B Hadaschik, FL Giesel, M Hartenbach, ... Journal of Nuclear Medicine 59 (3), 469-478, 2018 | 483 | 2018 |